Shine Investment Advisory Services’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Shine Investment Advisory Services’s Portfolio XBI Stock Details XBI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	$14K	Buy	+122	New	+$13.7K	﹤0.01%	504

Other funds holding XBI

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Shine Investment Advisory Services's XBI Position: Q3 2020 in Review

Shine Investment Advisory Services opened a new position in State Street SPDR S&P Biotech ETF (XBI) in Q3 2020: 122 shares worth $14K. The stake represents ﹤0.01% of the portfolio and ranks #504 among its holdings.

554 funds tracked by Wall St. Rank hold XBI as of Q3 2020.

Shine Investment Advisory Services held 122 shares of State Street SPDR S&P Biotech ETF worth $14K as of Q3 2020.
State Street SPDR S&P Biotech ETF was a new Shine Investment Advisory Services position in Q3 2020.
State Street SPDR S&P Biotech ETF made up ﹤0.01% of Shine Investment Advisory Services's portfolio in Q3 2020, its #504 holding.
554 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q3 2020.

Based on Shine Investment Advisory Services's 13F filing for Q3 2020, filed 3 Nov 2020.